A phase I/II study of the combination of panobinostat (PAN) and carfilzomib (CFZ) in patients (pts) with relapsed or relapsed/refractory multiple myeloma (MM)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 33; no. 15_suppl; p. 8513
Main Authors Berdeja, Jesus G., Gregory, Tara K., Matous, Jeffrey, Hart, Lowell L., Owera, Rami, Mace, Joseph Ronald, Essell, James H., Flinn, Ian, Faber, Edward Anthony
Format Journal Article
LanguageEnglish
Published 20.05.2015
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.8513